About Us

Overview

Manhattan Pharmaceuticals, Inc. is a specialty healthcare product company focused on developing and commercializing innovative treatments for underserved patient populations. Our current portfolio of product candidates includes:

AST-726 – a nasally delivered form of hydroxocobalamin for the treatment of vitamin B 12 deficiency
Hedrin® – a novel, non-pesticide treatment for pediculosis (head lice)
AST-915 – an oral treatment for essential tremor
GEL – a topical gel for the treatment of mild psoriasis

Manhattan Pharmaceuticals is located in New York City and is traded on the OTC Bulletin Board® under the ticker symbol “MHAN”.